Traws Pharma, Inc. — Director's Dealing 2014

Aug 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2014-05-22

Reporting Person: VANLENT ANNE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-22	Stock Option (right to purchase)	$4.52	A	10000	Acquired	2024-05-22	Common Stock (10000)	Direct

Footnotes

F1: These options vest over one year in 12 equal monthly installments.